|
Volumn 17, Issue 5, 2000, Pages 1063-1069
|
Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
DRUG DERIVATIVE;
GONADORELIN;
GONADORELIN RECEPTOR;
T 107;
TUMOR PROTEIN;
ADENOCARCINOMA;
ARTICLE;
CELL CULTURE;
CELL DIVISION;
CELL NUCLEUS;
COLLOID CARCINOMA;
CONFOCAL MICROSCOPY;
CYSTADENOCARCINOMA;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG SCREENING;
ENDOMETRIOID CARCINOMA;
ENDOMETRIUM TUMOR;
FEMALE;
HUMAN;
METABOLISM;
NEOPLASM;
OVARY TUMOR;
PATHOLOGY;
PHYSIOLOGY;
TRANSPORT AT THE CELLULAR LEVEL;
ADENOCARCINOMA;
ADENOCARCINOMA, MUCINOUS;
ADENOCARCINOMA, PAPILLARY;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL TRANSPORT;
CARCINOMA, ENDOMETRIOID;
CELL DIVISION;
CELL NUCLEUS;
CYSTADENOCARCINOMA, SEROUS;
DOXORUBICIN;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENDOMETRIAL NEOPLASMS;
FEMALE;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
MICROSCOPY, CONFOCAL;
NEOPLASM PROTEINS;
NEOPLASMS, HORMONE-DEPENDENT;
OVARIAN NEOPLASMS;
RECEPTORS, LHRH;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
EID: 0034322411
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.17.5.1063 Document Type: Article |
Times cited : (84)
|
References (0)
|